Our findings demonstrate that CAPE, particularly under IFN-α or combined LPS + IFN-α stimulation, enhances MMP-2 secretion, indicating that CAPE may influence glioma invasiveness through modulation of ECM-remodeling enzymes. Here, MMP2 is linked to central nervous system cancer.